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Background: Acetaminophen is both widely used to treat children with fever and is also 
responsible for thousands being hospitalised annually.  Historically the antipyretic actions of 
acetaminophen was attributed to the inhibition of cyclooxygenase (COX-1/2) enzymes and 
more recently a novel COX-1 variant (COX-3) located in the brain. However, the evidence 
for acetaminophen-mediated COX inhibition remains contentious. This study assesses the 
impact of acetaminophen and other putative COX-3 inhibitors on the release of fatty acids 
during lipolysis as an alternative mechanism by which antipyretics could reduce body 
temperature during fever.  
Experimental: 3T3-L1 adipocytes, primary brown adipocytes and isolated mitochondria 
were exposed to COX-3 inhibitors and lipolysis and mitochondrial electron transport chain 
function assessed.   
Results: Acetaminophen, aminopyrine and antipyrine at 1-10 mM caused a significant 
decrease (up to 70%; P<0.01, from control) in lipolysis within 1, 3 and 24 hours without 
affecting cell viability. The inhibition was observed regardless of where along its signalling 
pathway lipolysis was stimulated. All three compounds were found to significantly attenuate 
mitochondrial function by up to 30% for complex I and 40% for complex II (P<0.01, from 
control).  
Conclusions: These novel observations combined with the known limited inhibition of the 
COX enzymes by acetaminophen suggest both the antipyresis and hypothermia induced by 
acetaminophen and related compounds could be attributed to the direct inhibition of lipolysis 
and mitochondrial function, rather than cyclooxygenase inhibition centrally. Further these 
observations could provide new drug targets for reducing fever with the added bonus that 
fewer individuals being hospitalized by accidental acetaminophen overdose. 




Acetaminophen (Paracetamol) is one of the oldest and most widely used treatments for pain, 




































































questions remain about the exact mechanisms of action of acetaminophen. The analgesic 
properties are thought to be due to actions centrally on opioid, serotonergic and cannabinoid 
pathways (Sharma & Mehta, 2014) [1] . The anti-inflammatory and antipyretic actions of 
acetaminophen has traditionally been attributed to inhibition of the cyclooxygenase (COX) 
enzymes centrally (Hinz et al., 2008) [2]. However there is now extensive evidence to show 
that acetaminophen has only weak anti-inflammatory properties and this has been attributed 
to its limited inhibition of the COX-1 and COX-2 enzymes (Chandrasekharan et al., 2002; 
Botting & Ayoub 2005[3] [4]). In mammals fever is associated with increased COX-2/PGE₂ 
induction and activity. With the lack of COX inhibition by acetaminophen another target for 
the antipyretic actions of this widely used compound needed. 
During the last 20 years, many studies have revealed that the administration of 
acetaminophen (>100 mg/kg) to non-febrile rodents, for which there is no COX-2 induction 
results in hypothermia. One explanation which initially gained significant support was that 
acetaminophen is inhibiting a novel COX-1 variant (COX-3). It was proposed that the protein 
(COX-3) which was suggested to be specifically inhibited by acetaminophen is constitutively 
expressed in rodents to regulate body temperature (Chandrasekharan et al., 2002; Ayoub et al 
2004) [3] [5]. The COX-3 hypothesis was further supported by the observation that other 
drugs such as aminopyrine and antipyrine which are also antipyretics, have been suggested to 
be putative COX-3 inhibitors, also produce hypothermia in mice (Chandrasekharan et al, 
2002; Ayoub et al, 2004) [3] [5].  However, the hypothermic actions of acetaminophen is also 
observed in non-febrile animals such as the rat and in humans where the COX-3 protein 
cannot theoretically be expressed (Foster et al 2016; Kis et al, 2005) [6] [7]. Consequently an 
alternative hypothesis is needed to explain the acetaminophen-induced hypothermia observed 
in non-febrile animals and this could provide an explanation for the antipyretic actions of 
acetaminophen in humans.  
In terms of thermoregulation, rodents (homeotherms) are capable of maintaining their core 
body temperature (Tc) within a fairly constant range (36.0-37.5°C). However, due to their 
large surface area to mass ratio, small mammals must increase their metabolic heat 
production to regulate Tc when housed at temperatures below their thermoneutral zone 
(Gordon, 2012) [8].  To maintain Tc, rodents rely on the stimulation of lipolysis, a catabolic 
process resulting in the conversion of triglycerides (TG) stored in adipocytes to free fatty 
acids (FA) and glycerol, the FA are then oxidised in the  mitochondria  to generate heat 




































































laboratory mice temperatures below 30°C, the process begins with the release of adrenergic 
neurotransmitters from sympathetic fibres which binds to β₃-receptors located on surface of 
adipocytes leading to the activation of adenylate cyclase. This initiated an increase in cAMP 
levels, the activation of Protein Kinase A (PKA) and the phosphorylation of the lipolytic 
enzymes initiating lipolysis (Luo & Liu, 2016; Ueta et al., 2012) [9] [10]. A similar process 
of brown adipose tissue activation and lipolysis is also observed in humans following 
prolonged cold exposure (Lesna´ et al., 1999) [11]. 
In most laboratory situations, mice are housed at around 20–24°C (Gordon, 1993, 2004) [12] 
[13]. With their thermoneutral zone around 30°C they must respond to the mild cold stress by 
increasing their basal metabolic rate to avoid hypothermia (Gordon, 1985, 1990, 1993) [14] 
[15] [12].  It is therefore reasonable to hypothesize that animals housed under such conditions 
may be more susceptible to hypothermia if exposed to compounds which even mildly 
decrease the availability of FA and or compromise mitochondrial function. 
To better understand the mechanisms by which acetaminophen and other related antipyretics 
could either reduce fever or induce hypothermia in non-febrile animals. Studies were 
undertaken to assess the impact of acetaminophen, aminopyrine and antipyrine on rate of 
lipolysis in adipocytes and on the functioning of key complexes in the electron transport 
chain of isolated mitochondrial.  
 
Methods and Materials 
 
Chemicals 
All chemical were supplied by Sigma Chemical, Dorset, UK unless stated otherwise. 
 
Cell culture and differentiation of 3T3 L1 pre-adipocytes. 
The mouse 3T3-L1 pre-adipocyte cells (Public Health England, U.K.) were maintained under 
standard culture conditions (37°C, 5% CO₂, 95% air) with medium containing DMEM 
supplemented with 10% FBS, 2 mM glutamine, 10,000 units penicillin/ml, 10 mg 




































































medium). Cell were seeded at 10-20,000 cells/cm² and sub-cultured every 3 days at about 70-
80% confluent using 0.25% trypsin and 0.03% EDTA. 
For differentiation the cells were allowed to become confluent then allowed to grow for four 
additional days and this was treated as Day 0. At day 1, cells were placed in DMEM 
differentiation medium with 10% fetal bovine serum, 1 µg/ml insulin, 0.5 mM 
isobutylmethylxanthine (IBMX), 1 µM dexamethasone, 2 µM rosiglitazone for 48 hours. On 
day 3, the differentiation medium was switched to DMEM containing 10% FBS and 1 µg/ml 
insulin and changed after every 48 hours from this stage until fully differentiated 3T3-L1 
adipocytes formation: Public Health England, U.K. (Zebisch et al., 2012) [16]. 
Differentiation was confirmed by Oil Red O staining (Moreno-Aliaga & Matsumura, 1999) 
[17]. Viability was assessed by the MTT assay (Van Munster, et al., 1993) [18]. 
Isolation of rat primary brown adipocytes 
Primary brown fat adipocytes was isolated from Wistar rats (200g) purchased from Envigo 
UK. The animals were killed by cervical dislocation and brown adipose tissue from the 
interscapular depots was dissected out and placed on a parafilm in a small volume of 
Krebs/Ringer phosphate buffer. The cells were isolated as described by (Cannon & 
Nedergaard, 2008) [19]. Once isolate the cells were incubated in a 24 well place and viability 
and lipolysis determined. 
Determination of lipolysis assay in differentiated 3T3-L1 adipocytes and brown 
adipocytes.3 
For all experiments the cells were incubated in serum-free medium for 2 hours (Schweiger et 
al., 2014) [20]. The cells were then exposed to different concentrations of the lipolysis 
stimulants in medium containing  2% BSA (fatty acid free) and glycerol release was 
measured after 1, 3 and 24 hours, for basal lipolysis no stimulant was added. In tests 
involving the inhibitors (acetaminophen, aminopyrine and antipyrine) they were added 30 
minutes before the stimulants. At the end of the incubation period the 25 µL of the incubation 
medium would be taken for storage at -20˚C for assay later. To determine the level of 
glycerol the 25 µL of each sample was transferred to a new 96-well plate and 100 µL of 
glycerol reagent was added and read at 540 nm (Sigma-Aldrich, U.K.). The concentration of 
glycerol was determined from a calibration curve (Luo & Liu, 2016) [9].  




































































Mitochondria was removed and isolated from Wistar rats (200g) as described by Sandoval- 
Sandoval-Acuna, et al., (2012) [21]. 
 
Determination of Complex I activity  
The activity of NADH-ubiquinone oxidoreductase (complex 1) was determined by measuring 
the reduction of 0.05mM of the electron acceptor 2,6-dinitrophenolindophenol (DCPIP) and 
NADH (0.05mM) in the presence of either acetaminophen, aminopyrine or antipyrine at 
600nm. Complex 1 activity was confirmed using complex 1 inhibitor rotenone (0.1mM). The 
reaction mixture consisted of potassium phosphate buffer (35mM, pH 7.4) in the presence 
and absence of KCN and antimycin A. The reaction was started by adding the mitochondria 
homogenate (6.22mg/ml) and incubated for 10 minutes at room temperature (37ºC). 
 
Determination of Complex II activity  
The activity of Succinate–Ubiquinone Oxidoreductase activity (Complex II) activity was 
determined by measuring the reduction of DCPIP (0.05mM) in the presence of succinate (5- 
100mM) and either acetaminophen, aminopyrine or antipyrine, or a range of antipyretic 
agents at 600nm. The reaction mixture consisted of potassium phosphate buffer (35mM, pH 
7.4) in the presence and absence of KCN (0.5mM) and antimycin A (0.5mM) over 5-100mM 
of succinate. Complex II activity was confirmed using malonate (0.1mM).The reaction was 
started by adding the mitochondria homogenate (6.22mg/ml) and incubated for 10 minutes at 
room temperature (37ºC). 
The results were analysed using analysis of variance (ANOVA), followed by Dunnett's 








































































The effect of Acetaminophen, Aminopyrine and Antipyrine on basal lipolysis in rat 
primary brown adipocytes. 
Prior to the lipolysis studies, the cells were assessed for the impact of acetaminophen (PA), 
aminopyrine (AP) and antipyrine (AT) at concentrations up to 10 mM on cell viability. The 
concentrations of the antipyretics used in these studies were within the range normally 
associated with hypothermia in vivo: Fischer et al., (1981) [22]; Orbach et al., (2017) [23]. 
The compounds had no effect on the viability of primary adipocytes (24 hours) and up to 48 
hours for 3T3-L1 cells (data not shown). 
Glycerol release was assayed as an indicator of the extent of lipolysis Schweiger et al., 
(2014) [20]. The primary brown fat adipocytes had a high level of basal glycerol release 
which did not significantly increase on stimulation. Treatment of primary brown adipocytes 
with acetaminophen at concentrations (1 mM and 10 mM) reduced basal glycerol release 
(10% and 19%) at 1 hour and (19% and 26%) at 24 hours (Figure 3.1). Similarly, 
aminopyrine (1 mM and 10 mM) attenuated glycerol release (22% and 17%) at 1 hour and 
(34% and 26%) at 24 hours (Figure 3.2). Antipyrine treatment resulted in a smaller but 
significant decrease in glycerol release (10% and 11%) at 1 hour and (21% and 19%) at 24 
hours (Figure 3.3).  
Effect of Acetaminophen on basal lipolysis in 3T3-L1 adipocytes 
In unstimulated 3T3-L1 adipocytes incubated with acetaminophen at concentrations up to 
10mM there was a significant decrease in glycerol release indicating a reduction in basal 
lipolysis similar to the primary brown adipocytes. This inhibitory effect can be seen from 1 
hour with a 47% decrease in glycerol levels, followed by 57% and 52% at 3 and 24 hours 
respectively suggesting maximum lipolysis occurs within hours of exposure to 
acetaminophen (Figure 3.4). 
Effect of Acetaminophen on Isoproterenol stimulated lipolysis in 3T3-L1 adipocytes  
The effect of acetaminophen on lipolysis stimulated by isoproterenol a β-adrenergic agonist 
was then examined. Addition of isoproterenol elevated glycerol release from adipocytes as 
compared with that under basal conditions (Figure 3.5A).  The glycerol release was both 
concentration and time dependent over 24 hours although the greater impact was with 




































































Addition of acetaminophen attenuated the glycerol release in a concentration dependent 
manner. Typically at the concentration of 0.001 µM isoproterenol, 1mM of acetaminophen 
attenuated glycerol release by 41% whereas at 10mM acetaminophen the attenuation was 
54%. A similar pattern was seen at 0.01 µM and 0.1 µM isoproterenol (Figure 3.5-6 B-D). 
 
Effect of Acetaminophen on Forskolin stimulated lipolysis in 3T3-L1 adipocytes 
In order to assess the post receptor impact of acetaminophen, the adenylate cyclase activator 
forskolin was used (Bezaire et al,. 2009) [24]. Forskolin stimulated lipolysis in the 3T3-L1 
cells (Figure 3.7). Prior exposure to acetaminophen (10 mM) attenuated the lipolysis induced 
by forskolin by 32%, 35% and 46% at 1, 3 and 24 hours in Figure 3.7 B,D,F). 
 
 
Effect of acetaminophen on 8-Br-cAMP stimulated lipolysis in 3T3-L1 adipocytes 
The cAMP analog; 8-Br-cAMP stimulated lipolysis in the 3T3-L1 cells (Figure 3.8). In the 
cells in the presence of acetaminophen (10 mM) glycerol release was significantly attenuated 
at 3 hours (45%) and still persisted (40%) at 24 hours (Figure 3.8B) confirming that the 
acetaminophen effect could also be located beyond the cAMP level.     
     
Effect of Aminopyrine and Antipyrine on basal lipolysis in 3T3-L1 adipocytes  
In addition to acetaminophen other putative COX-3 inhibitors have also been shown to 
induce hypothermia including aminopyrine and antipyrine. In this study both compounds 
attenuated basal lipolysis at 1 and 24 hours to an extent similar to acetaminophen (Figure 
3.9).   
 
 
The effect of Acetaminophen Aminopyrine and Antipyrine on mitochondrial activity.  
 
Studies were also undertaken to determine the effect of acetaminophen, aminopyrine and 
antipyrine on the activity of complex I and complex II. At concentrations up to 10mM all the 
antipyretic compounds were found to inhibit complex I activity by decreasing the rate of 




































































compounds also attenuated complex II activity as demonstrated by the inhibition of malonate 
sensitive reduction DCPIP between 20-40% (Figure 3.11). The inhibition appears to be more 
pronounced at higher succinate concentrations. 
 
Discussion: 
Acetaminophen is probably the most widely used over the counter antipyretic worldwide, 
particularly for infants. Although it is very effective, there is still limited understanding about 
how it lowers body temperature in humans and in febrile animal models. The situation is 
further complicated because acetaminophen also causes hypothermia in non-febrile animals. 
One consequence of our lack of understanding of the exact mechanisms of action of 
acetaminophen is that every year thousands die or are hospitalised following acetaminophen 
use. A better understanding would allow the development of safer alternatives 
 
The focus of the present study is to understand how acetaminophen,  and other putative COX-
3 inhibitors;  aminopyrine and antipyrine could disrupt key cellular processes which 
determine heat generation, with a view to gaining a novel insight into the mechanism of 
action of antipyretics generally.  
For homeotherms such as laboratory rodents housed at temperatures below their 
thermoneutral zone there is a constant need to increase heat generation to avoid hypothermia. 
When homeotherms detect the external temperature is below their thermoneutral zone, a 
number of key responses are observed. One of the most important starts with signals from the 
preoptic area of anterior hypothalamus (POA) which stimulates peripheral effectors leading 
to the increase in lipolysis augmenting the amount of free fatty acids available for 
mitochondrial metabolism and heat generation. Given the lack of agreement about the 
effectiveness of acetaminophen at inhibiting cyclooxygenases centrally and peripherally, it is 
reasonable to examine the impact of this key antipyretic at other points along the mammalian 
heat generation pathway starting with lipolysis.  
Lipolysis is a critical metabolic function for adipocytes and is the key process that provides 
fatty acids for energy generation and to activate uncoupling protein 1, both are important for 




































































acids (lipolysis) is stimulated by β-adrenergic signalling on the cell surface of adipocytes. 
This leads to the activation of adenylate cyclase, increased levels of cAMP, the activation of 
PKA and the phosphorylation and activation of lipolytic enzymes including hormone 
sensitive lipase, adipose triglyceride lipase, and perilipin (Chrysovergis et al., 2014; 
McKnight et al., 1998; MacPherson & Peters, 2015; Schweiger et al., 2006; Heeren & 
Münzberg 2013; Marcelin & Chua, 2010) [26][27] [28] [29] [30] [31]. An essential 
requirement for all these process, from cell surface receptor signalling pathway, through to 
lipolysis and oxidation of the fatty acids, is the availability of ATP and functioning 
mitochondria. Any disruption or inhibition of mitochondrial function could potentially 
attenuate lipolysis with the consequent impact on heat generation leading to hypothermia. 
In this study prior to the lipolysis studies, the 3T3-L1 adipocyte cells were assessed for any 
direct impact of the antipyretics on viability. The concentrations selected (up to 10 mM) were 
similar to or lower than the plasma concentrations known to induce hypothermia in animals 
models and more importantly within the plasma concentrations required for antipyresis or 
hypothermia in humans (Fischer et al., 1981; Orbach et al., 2017) [22] [23]. At these 
concentrations over 24 hours, there was no loss of cell viability indicating that the effects 
observed could not be attributed to the loss of adipocytes.  
To examine whether the acetaminophen, aminopyrine and antipyrine could have a direct 
impact on lipolysis, the extent of glycerol was assessed. This is the most frequently used in 
vitro model and method to study lipolysis. To ensure detectable levels of lipolysis the 
adipocytes were incubated in a low glucose medium which forces the cells to metabolise fats 
for energy. Under basal conditions and without the presence of an adrenergic agonist, 
acetaminophen at 10 mM was found to significantly reduce glycerol release as early as 1 
hour. The fact that acetaminophen inhibited basal lipolysis suggested the effect could also be 
at a post receptor site or totally independent of adrenergic stimulation.  
To further investigate the impact of acetaminophen on the catecholamine receptor pathway, 
the β-agonist isoproterenol was selected to stimulate lipolysis. Adrenergic stimulated 
lipolysis is more likely to be observed in animals under cold stress such as rodents housed at 
22˚C. In these studies acetaminophen also inhibited isoproterenol induced lipolysis.  This 
observation prompted the question as to where along the adrenergic pathway acetaminophen 
was acting. The attenuation of the basal lipolysis has already confirmed that at least some of 




































































investigate whether acetaminophen was affecting the binding to the β-receptor, forskolin was 
used. A direct activator of adenylate cyclase, forskolin was able to stimulate lipolysis and 
which was also attenuated by acetaminophen (Bezaire et al,. 2009) [24]. This observation 
suggests acetaminophen inhibition is less likely to be at the β-receptor as forskolin work 
downstream of receptor binding.   
The next step was to investigate the effect of acetaminophen beyond the adenylate cyclase 
stage of the signalling pathway.  To determine the impact of acetaminophen post adenylate 
cyclase, the cAMP analog 8-Br-cAMP was employed. This compound is able to enhance the 
activity of protein kinase A thereby phosphorylating the lipolytic enzymes without activation 
of adenylate cyclase. The addition of 8-Br-cAMP induced an increase in lipolysis and this 
was attenuated by acetaminophen, confirming that the effect of must be distal to the 
production of cAMP.  These observation confirm that the impact of acetaminophen was not 
on the adrenergic signalling pathway as acetaminophen inhibition was observed regardless of 
where in the signally pathway lipolysis was stimulated.  
In addition to acetaminophen, the effect of aminopyrine and antipyrine were also examined as 
these compounds are known to cause hypothermia in vivo in mice and were reported to be 
COX-3 inhibitors in vitro (Ayoub et al 2004; Chandrasekharan et al, 2002) [5] [3]. 
Antipyrine (phenazone) exhibits analgesic, antipyretic and antirheumatic activity. 
Aminopyrine (aminophenazone) is thought to possess greater antipyretic and analgesic 
activity, marked anti-inflammatory property but more toxic than antipyrine (Volz & Kellner, 
1980) [32]. However like acetaminophen, little is understood about the impact of these 
compounds on lipolysis and how this relates to thermogenesis.  In the present study, both 
aminopyrine and antipyrine were effective at significantly attenuating glycerol release in a 
manner similar to acetaminophen. This is a novel observation and like acetaminophen could 
be linked to antipyresis.  
Although the differentiated 3T3-L1 cells are the most widely used in vitro model for studying 
lipolysis and fat metabolism, investigations were also undertaken using freshly isolated rat 
primary brown adipocytes. As primary cells they should provide a more realistic picture of 
the effect of the test compound on lipolysis in vivo. The primary brown adipocytes cells 
showed high levels of basal lipolysis which may reflect the fact that they had recently been 
removed from animals that have acclimatized to living at ambient temperatures which are 




































































basal lipolysis made it difficult to increase the level of lipolysis. However the compounds 
(acetaminophen, aminopyrine and antipyrine) inhibited lipolysis in the primary cells in a 
manner similar to the 3T3-L1 cells. Given the surface area to mass ratio of small mammals 
such as rodents any slight reduction heat generation would affect Tc. Consequently, when 
such animals are housed at temperatures below their thermoneutral zone, any reduction in 
lipolysis would compromise their ability to thermo-regulate. This may explain the 
hypothermia observed when these animals are exposed to acetaminophen, aminopyrine and 
antipyrine. 
Although this is the first time acetaminophen, aminopyrine and antipyrine have been shown 
to inhibit lipolysis they are not the only antipyretic compounds which have been shown to 
inhibit lipolysis. Indomethacin has been shown to inhibit enzymes involved in basal and 
stimulated lipolysis in the kidney (Erman et al., 1980) [33].  Other NSAIDs (aspirin, 
naproxen, nimesulide, and piroxicam) are known to activate the NADPH oxidase (NOX) 
isoform (NOX4) in adipocytes to produce hydrogen peroxide (H₂O₂), which impairs cAMP-
dependent PKA-II activation, thus inhibiting isoproterenol activated lipolysis. H₂O₂ 
signalling is a novel COX independent effect of NSAIDs in adipocytes and may play a role in 
antipyresis (Vázquez-Meza et al., 2013) [34]. 
Although lipolysis is a key step in the thermogenesis process, acetaminophen and other 
hypothermic compounds could also work at sites downstream to the release of fatty acids 
from triglycerides, for example by directly inhibiting mitochondrial function.  Given the lack 
of inhibition of adrenergic signalling pathway in this study, further studies were conducted 
using isolated mitochondria. As previously stated, energy generation for thermoregulation 
require functioning mitochondria. In the present study all three compounds; acetaminophen, 
aminopyrine and antipyrine were shown to attenuated mitochondrial activity at complex I and 
complex II.  Without fully functioning mitochondria both lipolysis and fatty acid oxidation 
will be compromised, and this would directly lead to hypothermia in small mammals such as 
rodents. 
It has always been difficult to reconcile the pharmacological actions of acetaminophen 
particularly the antipyretic effects with the weak inhibition of cyclooxygenase enzymes.  The 
novel observations in this study provide a logical and plausible explanation as to how 
acetaminophen could cause both hypothermia and antipyresis distinct from any impact on 




































































negatively impact on how small mammals thermoregulate at environmental temperatures 
below their thermoneutral zone.  These observations could explain the hypothermia widely 
reported when some antipyretic compounds are administered to rodents at concentrations 
normally required for antipyresis. Similarly during fever hyperthermia is driven by increased 
metabolism including increased lipolysis and mitochondrial function. The attenuating effect 
on lipolysis and mitochondrial function of these antipyretic agents observed in this study 
could provide an alternative peripheral mechanism of the action for acetaminophen and many 
other compounds which is independent of cyclooxygenase inhibition both centrally and 
peripherally.   
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Figure 3.1 Effect of acetaminophen on basal lipolysis in rat primary brown adipocytes at 1 
and 24 hours: Brown adipocytes were treated with different concentrations of 
acetaminophen and glycerol release was measured at 1(A) and 24(B) hours.  Data are 
representative of n=4 replicates expressed as means ± Standard deviations (**P < 0.01 from 
control). 
 
Figure 3.2 Effect of aminopyrine on basal lipolysis in rat primary brown adipocytes at 1 
and 24 hours: Brown adipocytes were treated with different concentrations of aminopyrine 
and glycerol release was measured at 1(A) and 24(B) hours.  Data are representative of n=4 
replicates expressed as means ± Standard deviations (**P < 0.01 from control). 
 
Figure 3.3 Effect of antipyrine on basal lipolysis in rat primary brown adipocytes at 1 and 
24 hours: Brown adipocytes were treated with different concentrations of antipyrine and 
glycerol release was measured at 1(A) and 24(B) hours. Data are representative of n=4 
replicates expressed as means ± Standard deviations (**P < 0.01 from control). 
   
 Figure 3.4 Effect of acetaminophen on basal lipolysis in 3T3-L1 adipocytes at 1, 3 and 24 
hours: Differentiated 3T3-L1 adipocytes were treated with serum free DMEM for 2 hours 




































































lipolysis, cells were treated at the same time with an appropriate volume of vehicle. Lipolysis 
was determined by measuring glycerol released into the culture media at 1(A), 3(B) and 
24(C) hours. Data are representative of n=4 replicates expressed as means ± Standard 
deviations (*P < 0.05, **P < 0.01 from control).  
 
Figure 3.5 Effect of acetaminophen on isoproterenol stimulated lipolysis in 3T3-L1 
adipocytes at 1 hour: Differentiated 3T3-L1 adipocytes were treated with serum free DMEM 
for 2 hours. Cells were either treated with different concentrations of isoproterenol (Iso) 
alone (A) or treated with different concentrations of acetaminophen and isoproterenol added 
simultaneously (B-D). Lipolysis was determined by measuring glycerol released into the 
culture media at 1 hour. Data are representative of n=4 replicates expressed as means ± 
Standard deviations (*P < 0.05, **P < 0.01 from control). 
 
Figure 3.6 Effect of acetaminophen on isoproterenol stimulated lipolysis in 3T3-L1 
adipocytes after 24 hours: Differentiated 3T3-L1 adipocytes were treated with serum free 
DMEM for 2 hours. Cells were either treated with different concentrations of isoproterenol 
alone (A) or treated with different concentrations of acetaminophen and isoproterenol added 
simultaneously (B-D). Lipolysis was determined by measuring glycerol released into the 
culture media at 24 hours. Data are representative of n=4 replicates expressed as means ± 
Standard deviations (*P < 0.05, **P < 0.01 from control).                                                                                
 
Figure 3.7 Effect of acetaminophen on forskolin stimulated lipolysis in 3T3-L1 adipocytes 
at 1(A), 3(B) and 24(C) hours: Differentiated 3T3-L1 adipocytes were treated with serum 
free DMEM for 2 hours. Cells were either treated with forskolin (Fsk) alone (A) or 
preincubated with different concentrations of acetaminophen for 30 minutes and then 
forskolin added (B). Lipolysis was determined by measuring glycerol released into the 
culture media at 1(A,B), 3(C,D) and 24(E,F) hours. Data are representative of n=4 





































































Figure 3.8 Effect of acetaminophen on 8-Br-cAMP stimulated lipolysis in 3T3-L1 
adipocytes at 3 and 24 hours: Differentiated 3T3-L1 adipocytes were treated with serum free 
DMEM for 2 hours. Cells were either treated with 8-Br-cAMP alone (A) or preincubated 
with different concentrations of acetaminophen for 30 minutes and then 8-Br-cAMP added 
(C). Lipolysis was determined by measuring glycerol released into the culture media at 
3(A,C) and 24(B,D) hours. Data are representative of n=4 replicates expressed as means ± 
Standard deviations (*P < 0.05, **P < 0.01 from control). 
 
Figure 3.9 Effect of aminopyrine and antipyrine on basal lipolysis in 3T3-L1 adipocytes at 
1, 3 and 24 hours: Differentiated 3T3-L1 adipocytes were treated with serum free DMEM for 
2 hours and were then treated with aminopyrine (AM) or antipyrine (AT). Lipolysis was 
determined by measuring glycerol released into the culture media at 1(A), 3(B) and 24(C) 
hours. For basal lipolysis, cells were treated at the same time with an appropriate volume of 
vehicle. Data are representative of n=4 replicates expressed as means ± Standard deviations 
(**P < 0.01 from control). 
 
 
Fig 3. 10 The effect of antipyretic compounds on mitochondrial complex I activity. 
Mitochondria were incubated with 5mM of either acetaminophen (Para) Antipyrine (AT) and 
Aminopyrine (AM) for 10 mins in the presence of NADH (0.05mM).  The reduction of DCPIP 
at 600nm was monitored for 3 minutes. Values represents the mean ± SD (N= 7). The 
significance of difference was determined using a one way ANOVA followed by a Dunnett’s 
multiple of comparison post hoc test.  **p< 0.001 was statistically significant compared to 
the control. 
 
Fig 3.11 The effect of acetaminophen, aminopyrine and antipyrine on complex II activity 
in rat liver mitochondria. A concentration of 5mM of the test compounds was added to a 
reaction mixture containing DCPIP and mitochondria suspension. Varying concentration of 
succinate (20mM-100mM) was used and absorbance at 600nm was monitored for 3mins. 
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 In terms of antipyresis  and hypothermia, the peripheral actions of acetaminophen and 
related compounds are more important than inhibition of cyclooxygenases centrally. 
 The antipyresis  and hypothermic effects of acetaminophen may be due to the inhibition of 
lipolysis.  
 The inhibition of mitochondrial electron transport chain by acetaminophen may explain both 
the antipyresis  and hypothermic effects. 
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